Cell Receptor SA Verified listing Verified listing

  • Swiss Biotech Association
    Not a member

Cell Receptor Inc. has IP for remarkably improving treatment results in oncology by targeting critical upstream steps of growth signaling, not noticed in oncology yet.

A well-tolerated treatment of low toxicity! It will prevent metastasis and chemoresistance in most cancers.

Location

Additional address info

  • c/o L&S Trust Services SA

Canton

Facts & figures

  • Type of organization
    Private company
  • Year of foundation
    2017
  • Number of employees in Switzerland
    1-9

Key business

You may also be interested in